Newer technologies designed to help people with type 1 diabetes monitor their blood sugar levels daily work better than traditional methods…. 

Three international diabetes groups have taken the first step toward developing a global initiative to improve diabetes care for older people…. 

Being older, male, or black significantly raised the risk for weight-loss failure after gastric bypass in a single-center study of more than 1,200 patients…. 

Eight-two percent of Americans are aware that being overweight is a key risk factor for diabetes, yet those at risk are not applying this logic to themselves…. 

The AHA and the ADA concluded in a position statement that using non-nutritive sweeteners could cut down on added sugars and therefore lead to beneficial effects. But an extensive literature search found sketchy, limited, and often contradictory evidence….

Patients with diabetes face choices in insulin delivery as well as glucose monitoring methods…. 

Sitting less than three hours a day adds two years to life expectancy….

Researchers are trying new approaches to treat type 2 diabetes amid widespread uncertainty about the most effective therapies and concerns that current strategies might be doing some patients more harm than good…. 

Healthy individuals without diabetes have similar increases in insulin secretion….

Dr. Mooney talks about the Symphony device’s testing in hospital settings, the prospects for FDA as well as European clearance, and the choices and strategies made to bring the Symphony to market. More videos with Dr. Mooney: Patrick Mooney, MD, CEO, Echo Therapeutics, Introduction Symphony tCGM System How Many Patients …